These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3543138)

  • 1. Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
    Schultz RM; Altom MG
    J Immunopharmacol; 1986; 8(4):515-28. PubMed ID: 3543138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
    Watanabe Y; Tawara S; Mine Y; Kikuchi H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.
    Inamura N; Nakahara K; Kino T; Gotoh T; Kawamura I; Aoki H; Imanaka H; Sone S
    J Biol Response Mod; 1985 Aug; 4(4):408-17. PubMed ID: 4031951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
    Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
    Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism of synthetic acyltripeptide and its analogs with recombinant interferon gamma for activation of antitumor properties of human blood monocytes.
    Sone S; Okubo A; Inamura N; Nii A; Ogura T
    Cancer Immunol Immunother; 1988; 27(1):33-7. PubMed ID: 3135118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
    Mine Y; Yokota Y; Wakai Y; Fukada S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1045-50. PubMed ID: 6415029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective activity of recombinant murine tumor necrosis factor-alpha and interferon-gamma against experimental murine lung carcinoma metastases.
    Schultz RM; Altom MG
    J Interferon Res; 1990 Apr; 10(2):229-36. PubMed ID: 2111356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.
    Kolodziejczyk AM; Kolodziejczyk AS; Stoev S
    Int J Pept Protein Res; 1992 Apr; 39(4):382-7. PubMed ID: 1428528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory and therapeutic properties of FK-565 in mice.
    Talmadge JE; Lenz B; Schneider M; Phillips H; Long C
    Cancer Immunol Immunother; 1989; 28(2):93-100. PubMed ID: 2521814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
    Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M
    J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine.
    Okada S; Takeno H; Hemmi K; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
    Dinney CP; Bucana CD; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1991 Jul; 51(14):3741-7. PubMed ID: 1905975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
    Ahmed K; Turk JL
    Cancer Immunol Immunother; 1989; 28(2):87-92. PubMed ID: 2783891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effects of FK156 in a panel of tests designed to detect changes in immune function.
    Weston BJ; Henderson DC; Seal S; Spackman V; Robertson F; Dewdney JM
    Int J Immunopharmacol; 1991; 13(2-3):117-24. PubMed ID: 2071288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation and host augmentation against Sendai or herpes simplex virus (HSV) infections with synthetic polypeptides in mice.
    Iida J; Nishi N; Saiki I; Mizukoshi N; Ishihara C; Tokura S; Azuma I
    Int J Immunopharmacol; 1989; 11(3):249-58. PubMed ID: 2544534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.